Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
GHK-Cu avoids systemic hormone disruption, making it safer for a broader range of individuals, including women
While Dihexa exerts its main action via HGF/c-Met potentiation, compounds such as Semax act primarily through Brain-Derived Neurotrophic Factor (BDNF) upregulation and melanocortin receptor modulation
Careful preparation protects peptide effectiveness during clinical research applications
The combination can be a game-changer for performance and recovery time
US$ 29.60
US$ 28.66
US$ 26.53
US$ 22.98
